Springfield, MO

Log in Subscribe

Merck to acquire cancer-treatment biotech firm

Posted online

Merck & Co. Inc. announced plans to purchase biopharmaceutical company Tilos Therapeutics.

The deal for the cancer-treatment biotechnology firm could be valued at up to $773 million.

The deal includes an up-front payment and milestone payouts.

Read more from MarketWatch.


No comments on this story |
Please log in to add your comment
Editors' Pick
Springfield’s rental picture marked by complexity

Developers say city needs a variety of housing types to meet demand.

Most Read Poll
What kind of housing does Springfield need more of?


View results

Update cookies preferences